par Dieli, F;Vermijlen, David ;Fulfaro, Fabio;Caccamo, N;Meraviglia, S;Cicero, G;Roberts, Andrew;Buccheri, S;D'Asaro, M;Gebbia, Nicola;Salerno, Alfredo;Eberl, M;Hayday, A C
Référence Cancer research, 67, 15, page (7450-7457)
Publication Publié, 2007-08
Référence Cancer research, 67, 15, page (7450-7457)
Publication Publié, 2007-08
Article révisé par les pairs
Titre: |
|
Auteur: | Dieli, F; Vermijlen, David; Fulfaro, Fabio; Caccamo, N; Meraviglia, S; Cicero, G; Roberts, Andrew; Buccheri, S; D'Asaro, M; Gebbia, Nicola; Salerno, Alfredo; Eberl, M; Hayday, A C |
Informations sur la publication: | Cancer research, 67, 15, page (7450-7457) |
Statut de publication: | Publié, 2007-08 |
Sujet CREF: | Immunologie |
MeSH keywords: | Aged |
Aged, 80 and over | |
Antineoplastic Agents -- therapeutic use | |
Bone Density Conservation Agents -- therapeutic use | |
Diphosphonates -- therapeutic use | |
Dose-Response Relationship, Drug | |
Drug Therapy, Combination | |
Feasibility Studies | |
Humans | |
Imidazoles -- therapeutic use | |
Immunotherapy -- methods | |
Interleukin-2 -- therapeutic use | |
Lymphocyte Activation -- drug effects | |
Male | |
Middle Aged | |
Neoplasms, Hormone-Dependent -- drug therapy | |
Prostatic Neoplasms -- drug therapy | |
Receptors, Antigen, T-Cell, gamma-delta | |
Remission Induction | |
Salvage Therapy | |
T-Lymphocytes -- cytology -- drug effects -- immunology | |
Treatment Outcome | |
Note générale: | Journal Article |
Research Support, Non-U.S. Gov't | |
Langue: | Anglais |
Identificateurs: | urn:issn:0008-5472 |
info:doi/10.1158/0008-5472.CAN-07-0199 | |
info:pii/67/15/7450 | |
info:scp/34547638252 | |
info:pmid/17671215 |